Gastric Inhibitory Polypeptide (6-30) amide (human) CAS 1139691-72-7
| CAS No. | 1139691-72-7 |
| Molecular Formula | C139H209N35O38S |
| Molecular Weight | 3010.47 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Gastric Inhibitory Polypeptide (6-30) amide (human) is closely related to a nitrogen-containing heterocyclic scaffold, an amide group, a sulfone group, a hydroxyl group, an ether linkage in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
Gastric Inhibitory Polypeptide (6-30) amide (human) (CAS 1139691-72-7) is a high-purity analytical reference standard with the molecular formula C139H209N35O38S and a molecular weight of 3010.47 g/mol.
The molecular framework of Gastric Inhibitory Polypeptide (6-30) amide (human) (C139H209N35O38S) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a sulfone group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
CATO manufactures Gastric Inhibitory Polypeptide (6-30) amide (human) under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C139H209N35O38S |
| Molecular Weight | 3010.47 g/mol |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 53.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1989 |
| Nitrogen Atoms | 35 |
| Sulfur Atoms | 1 |
Related Gastric Standards
Recommended Standards
- Hepatitis B Virus Pre-S Region (120-145) (CAS 104504-34-9)
- PHI-27 (rat) (CAS 96849-38-6)
- Neuropeptide Y (13-36) (human, rat) (CAS 122341-40-6)
- Peptide YY (13-36) (canine, mouse, porcine, rat) (CAS 86895-09-2)
- Tert-butyl 3-benzyl-3-formylpiperidine-1-carboxylate (CAS 1355334-49-4)
- ETHYL 3-METHYL-7-OXO-6,7-DIHYDRO-5H-CYCLOPENTA[C]PYRIDINE-6-CARBOXYLATE (CAS 1026417-03-7)
- 1-(3-(Hydroxymethyl)pyrrolidin-1-yl)pentan-1-one (CAS 1250517-57-7)
- 3-Chloro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylic acid (CAS 1555667-48-5)
- 1H-Indole-3-carbonitrile, 5,7-dichloro-1-methyl- (CAS 1539840-84-0)
- 1H-indole, 3-iodo-5-methoxy-1-(phenylsulfonyl)- (CAS 86335-42-4)
- 3-Oxoisoindolin-5-ylboronic acid (CAS 1370535-30-0)
- cis-4-Amino-1-boc-3-hydroxypiperidine (CAS 1331777-74-2)
- 4-Bromo-3-chloro-N-cyclopropyl-2-fluorobenzamide (CAS 2404733-68-0)
- ([D2]Gly4)-Cholecystokinin Octapeptide (sulfated) ammonium salt (CAS 1926163-74-7)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com